NCT00260611: Study of Oxaliplatin and Taxotere in Prostate Cancer |
|
|
| Completed | 2 | 34 | US | Oxaliplatin, eloxatin, Taxotere, Docefrez, Docetaxel | University of Pittsburgh, Sanofi | Prostate Cancer | 09/07 | 09/07 | | |
NCT01338792: Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer |
|
|
| Completed | 2 | 47 | US | oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, pemetrexed disodium, ALIMTA, LY231514, MTA, questionnaire administration, laboratory biomarker analysis, reverse transcriptase-polymerase chain reaction, RT-PCR, polymorphism analysis | University of Southern California, National Cancer Institute (NCI) | Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer | 12/11 | 12/12 | | |
